Tom's of Maine toothpaste made with bacteria-contaminated water, says FDA
An inspection of a Tom's of Maine manufacturing facility found that the brand's toothpaste was produced with water containing ...
Sangamo Therapeutics Gets FDA Clearance for Investigational NDA for Pain Treatment
Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.
Zacks Small Cap Research on MSN21h
RVPH: Year-End OLE Update
RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...
CNS Drug Development: Same As It Ever Was
Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.